Allergan switches Lastacaft to OTC status in the US

17 March 2022 - Deborah Wilkes

Premium

Allergan has switched Lastacaft eye drops containing the active ingredient alcaftadine from prescription-to-OTC status in the US.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: